RESPOND-2

• Research type

  Research Study

• Full title

  A Phase 3 Safety and Efficacy Study of Boceprevir in Subjects With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment with Peginterferon/Ribarvirin.

• IRAS ID

  3968

• Contact name

  Ashley Brown

• Contact email

  ashley.brown@imperial.nhs.uk

• Sponsor organisation

  Schering Plough Research Institute

• Eudract number

  2007-005151-42

• ISRCTN Number

  N/A

• REC name

  London - City & East Research Ethics Committee

• REC reference

  08/H0703/92

• Date of REC Opinion

  22 Oct 2008

• REC opinion

  Further Information Favourable Opinion